What is a coronary calcium score and what does it indicate regarding cardiovascular risk?

What is a Coronary Calcium Score and What Does It Indicate?

A coronary artery calcium (CAC) score is a non-invasive CT measurement that quantifies calcified atherosclerotic plaque in the coronary arteries, serving as one of the strongest independent predictors of future cardiovascular events and providing definitive evidence of coronary atherosclerosis. 1, 2

Technical Measurement

• The Agatston score is the most widely used CAC scoring system, defining calcific lesions as having CT density >130 Hounsfield units with area >1 mm², calculated by multiplying lesion area by a density-weighting factor of 1-4 3
• The scan uses ECG-gated multidetector computed tomography without contrast, with relatively low radiation exposure (0.37-1.5 mSv)—comparable to 1-2 mammograms per breast 3, 1
• Total CAC score is computed by summing scores of all calcified lesions across all coronary arteries and can be expressed as a percentile adjusted for age, sex, and race 3

What the Score Indicates About Atherosclerosis

• Coronary calcifications are exclusively present in atherosclerotic lesions of the intimal layer—calcium does not occur in normal vessel walls, so any detectable calcium definitively establishes the presence of atherosclerosis 1
• The degree of coronary calcification correlates with the extent of total atherosclerotic burden, with cardiovascular risk increasing proportionally as CAC scores increase 3, 1
• However, CAC represents only approximately 20% of total atherosclerotic plaque burden because it cannot detect non-calcified plaques, which may be present in earlier stages of disease 1, 4

Critical Limitation: CAC Does Not Measure Stenosis

• CT calcium scoring has poor specificity for diagnosing obstructive coronary artery disease due to the modest relationship between calcification and luminal obstruction 1
• In symptomatic patients with zero calcium score, 3.5% still had ≥50% arterial stenosis and 1.4% had ≥70% stenosis 1
• Lumen patency is often preserved by vascular remodeling, so CAC should be seen primarily as a marker of atherosclerosis burden and not of degree of stenosis 1, 2

Risk Stratification Categories

The traditional CAC categories and their cardiovascular risk implications are 3, 1:

• CAC = 0: Excellent prognosis with annual risk of cardiac death or MI <1% (specifically 0.16%/year); in a systematic review of 71,595 asymptomatic patients, only 0.47% had adverse cardiovascular events over 50-month follow-up 3, 5
• CAC = 1-99: Mild atherosclerosis with incrementally increased risk above zero; confirms presence of disease and warrants lifestyle modification and consideration of statin therapy, especially if score is ≥75th percentile for age/sex/race 1
• CAC = 100-399: Moderate atherosclerosis indicating ≥7.5% 10-year ASCVD risk regardless of demographic subset; statin therapy benefits clearly exceed potential harm with NNT of 30-42 over 5 years 3, 1
• CAC ≥ 400: Severe atherosclerosis with extensive burden; relative risk 7.2-10.8 fold higher than CAC=0, with 3-5 year CHD death/MI rates of 4.6%-7.1%; requires aggressive preventive therapy including high-intensity statins 3, 1

The "Power of Zero"

• When CAC = 0, patients have a highly favorable prognosis with yearly mortality <1% for more than 15 years—lower than mortality predicted by Framingham risk score even for low-risk individuals 3
• A zero CAC score was a stronger indicator than typical risk factors: mortality was lower for CAC=0 patients than for those with no cardiovascular risk factors 3
• Even patients classified as high risk (>20%) by Framingham score had <1% mortality for the first 5 years when CAC = 0 3
• The concept of a "warranty period" when CAC = 0 means the score can be used to adjust typical mortality expectations and potentially defer statin therapy 3, 6

Important Caveats About Zero Scores

• In diabetic patients, the protective effect of CAC=0 diminishes after 5 years—diabetic patients show a nonlinear increase in mortality compared to non-diabetic patients beyond 5 years (P<0.05) 3
• The warranty period is shortened by traditional cardiovascular risk factors, emphasizing the need for continued risk-factor management 1
• Age markedly influences risk: an 80-year-old with CAC=0 has an event rate comparable to an average 50-year-old without risk factors 1

Clinical Applications for Risk Assessment

• CAC scoring is most valuable for risk stratification in asymptomatic individuals aged 40-75 years with intermediate (7.5-20%) or borderline (5-7.5%) 10-year ASCVD risk when decisions about preventive therapy are uncertain 1, 2
• The 2019 ACC/AHA guidelines give CAC scoring a Class IIa recommendation (reasonable to perform) for intermediate-risk patients to guide statin therapy decisions 1
• Intermediate-risk patients without coronary calcification can be reclassified into a lower-risk group, potentially avoiding statin therapy 1, 2
• In the Multi-Ethnic Study of Atherosclerosis, adding CAC to traditional risk factors resulted in significant improvements in risk prediction (net reclassification improvement = 0.25; P<0.001), with an additional 23% of those who experienced events reclassified as high risk 7

When CAC Scoring Should NOT Be Used

• Not recommended for symptomatic patients with chest pain or known CAD, as CAC=0 does not exclude obstructive disease (7-38% of symptomatic patients with CAC=0 have obstructive CAD) 1
• Not appropriate for truly low-risk asymptomatic patients (<5% 10-year ASCVD risk) because the test does not provide actionable information that changes management 1
• Not recommended for men under 40 and women under 50 years due to low prevalence of calcification in younger individuals 1, 2
• Should not be used as a surrogate for angiographic disease detection or to determine need for revascularization 1

Screening for Silent Ischemia

• The 2010 ACC/AHA guidelines recommend screening for clinically silent ischemia when CACS >400, though this is only a weak (Class IIb) recommendation 3, 1
• Cardiovascular risk increases especially when CACS >300-400, and stress testing may be considered at these thresholds particularly if symptoms or additional high-risk features are present 3, 1

Repeat Scanning Intervals

• For CAC = 0: repeat in 5-10 years if risk factors persist (diabetes, smoking, chronic inflammatory disease, strong family history) 1
• For CAC = 1-99: repeat in 3-5 years when results could influence treatment decisions 1
• For CAC ≥ 400: do not repeat CAC scanning as patients are already classified as high risk and should receive aggressive therapy 1